DGI:ZNS-Infektionen/Tuberkulose Meningitis/Quellen: Unterschied zwischen den Versionen
Keine Bearbeitungszusammenfassung |
Keine Bearbeitungszusammenfassung |
||
| Zeile 1: | Zeile 1: | ||
* Amagon KI, | * Amagon KI et al., Methionine and vitamin B-complex ameliorate antitubercular drugs-induced toxicity in exposed patients. Pharmacol Res Perspect. 2017;5(5). doi:10.1002/prp2.360 | ||
* Chin JH. Tuberculous meningitis: Diagnostic and therapeutic challenges. Neurol Clin Pract. 2014;4(3):199-205. doi:10.1212/CPJ.0000000000000023 | * Chin JH. Tuberculous meningitis: Diagnostic and therapeutic challenges. Neurol Clin Pract. 2014;4(3):199-205. doi:10.1212/CPJ.0000000000000023 | ||
* Ducomble T | * Ducomble T et al., The burden of extrapulmonary and meningitis tuberculosis: an investigation of national surveillance data, Germany, 2002 to 2009. Euro Surveill. 2013;18(12):20436. | ||
* Marais S | * Marais S et al., Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis. 2010;10(11):803-812. doi:10.1016/S1473-3099(10)70138-9 | ||
* National Collaborating Centre for Chronic Conditions (UK), Centre for Clinical Practice at NICE (UK). Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for Its Prevention and Control. National Institute for Health and Clinical Excellence (UK); 2011. Accessed August 9, 2021. <nowiki>http://www.ncbi.nlm.nih.gov/books/NBK97852/</nowiki> | * National Collaborating Centre for Chronic Conditions (UK), Centre for Clinical Practice at NICE (UK). Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for Its Prevention and Control. National Institute for Health and Clinical Excellence (UK); 2011. Accessed August 9, 2021. <nowiki>http://www.ncbi.nlm.nih.gov/books/NBK97852/</nowiki> | ||
* Prasad K, | * Prasad K et al., Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. 2016;4:CD002244. doi:10.1002/14651858.CD002244.pub4 | ||
* Schaberg T | * Schaberg T et al., [Tuberculosis Guideline for Adults - Guideline for Diagnosis and Treatment of Tuberculosis including LTBI Testing and Treatment of the German Central Committee (DZK) and the German Respiratory Society (DGP)]. Pneumologie. 2017;71(6):325-397. doi:10.1055/s-0043-105954 | ||
* Thwaites GE | * Thwaites GE et al., Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004;351(17):1741-1751. doi:10.1056/NEJMoa040573 | ||
* Thwaites G | * Thwaites G et al., British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect. 2009;59(3):167-187. doi:10.1016/j.jinf.2009.06.011 | ||
* Wilkinson RJ | * Wilkinson RJ et al., Tuberculous meningitis. Nat Rev Neurol. 2017;13(10):581-598. doi:10.1038/nrneurol.2017.120 | ||
* Lange C et al. , Update: Therapie der medikamentenresistenten Tuberkulose (DR-TB) in Deutschland, Österreich und der Schweiz – Aktualisierte Empfehlungen auf Basis der WHO-Leitlinien 2025. Pneumologie 2026; 80: 160–167. https://doi.org/10.1055/a-2731-0729 | |||
* AWMF-Leitlinie: https://register.awmf.org/assets/guidelines/020-019l_S2k_Tuberkulose-im-Erwachsenenalter_2023-09.pdf | |||
Aktuelle Version vom 10. September 2026, 10:35 Uhr
- Amagon KI et al., Methionine and vitamin B-complex ameliorate antitubercular drugs-induced toxicity in exposed patients. Pharmacol Res Perspect. 2017;5(5). doi:10.1002/prp2.360
- Chin JH. Tuberculous meningitis: Diagnostic and therapeutic challenges. Neurol Clin Pract. 2014;4(3):199-205. doi:10.1212/CPJ.0000000000000023
- Ducomble T et al., The burden of extrapulmonary and meningitis tuberculosis: an investigation of national surveillance data, Germany, 2002 to 2009. Euro Surveill. 2013;18(12):20436.
- Marais S et al., Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis. 2010;10(11):803-812. doi:10.1016/S1473-3099(10)70138-9
- National Collaborating Centre for Chronic Conditions (UK), Centre for Clinical Practice at NICE (UK). Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for Its Prevention and Control. National Institute for Health and Clinical Excellence (UK); 2011. Accessed August 9, 2021. http://www.ncbi.nlm.nih.gov/books/NBK97852/
- Prasad K et al., Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. 2016;4:CD002244. doi:10.1002/14651858.CD002244.pub4
- Schaberg T et al., [Tuberculosis Guideline for Adults - Guideline for Diagnosis and Treatment of Tuberculosis including LTBI Testing and Treatment of the German Central Committee (DZK) and the German Respiratory Society (DGP)]. Pneumologie. 2017;71(6):325-397. doi:10.1055/s-0043-105954
- Thwaites GE et al., Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004;351(17):1741-1751. doi:10.1056/NEJMoa040573
- Thwaites G et al., British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect. 2009;59(3):167-187. doi:10.1016/j.jinf.2009.06.011
- Wilkinson RJ et al., Tuberculous meningitis. Nat Rev Neurol. 2017;13(10):581-598. doi:10.1038/nrneurol.2017.120
- Lange C et al. , Update: Therapie der medikamentenresistenten Tuberkulose (DR-TB) in Deutschland, Österreich und der Schweiz – Aktualisierte Empfehlungen auf Basis der WHO-Leitlinien 2025. Pneumologie 2026; 80: 160–167. https://doi.org/10.1055/a-2731-0729
- AWMF-Leitlinie: https://register.awmf.org/assets/guidelines/020-019l_S2k_Tuberkulose-im-Erwachsenenalter_2023-09.pdf